BioData2008 « Where Biopharma And Medtech Companies Meet Investors »

Wednesday, January 23rd, 2008 @ Ramada Park Hotel, Genève

BioData is the yearly international symposium based in Geneva, where leaders of biopharma and medtech companies meet investors.

BioData has been designed to inform venture capitalists, financial analysts and fund managers responsible for asset allocation of the current issues facing the biopharma and medtech industries.

Keynote lectures and panel discussions cover topics ranging from the role of the European Investment Fund in the promotion of Venture Capital in Europe, to the evolution of cancer markets. BioData will also include a strong focus on medical technology companies.

Invited speakers for keynote lectures and panel discussions include senior management representatives from biotech/medtech companies both in Europe and the United States as well as leading investment professionals from around the globe.

The 7th edition of BioData will take place at the Ramada Park Hotel in Geneva, 22-23 January 2008.

The full program is available on the BioData web site: www.biodataforum.com

PROGRAMME

Interactive session – Switzerland

“How to value innovation?”

Valuating innovation remains a challenge for both private and public companies. How many listed companies in Switzerland are trading below their IPO value today, despite significant progress in their R&D pipeline and increased cash position? Many argue that putting a value on early stage companies remains largely a gamble. On the other hand a number of trade sales and acquisitions of biotech companies by large pharma companies have demonstrated that innovation has tremendous value and can be highly cash generative. Is this gap widening? Is it only a buyers market? Is it possible to value innovation at a fair price? How can companies increase the valuation of their innovation?

Medtech panel

“Medtech companies: a new momentum in BioAlps and Rhône–Alpes region?”

Europe is a major source of innovation in the medical technology field. Historically, the development of new surgical procedures has been easier in Europe because of friendlier regulations than those of the FDA. Large companies such as Siemens and Philips in imaging and Synthes Stratec, Smith and Nephews or Aesculap in orthopedics provide great support for the development of new technologies in Europe. But technology hubs such as Grenoble have also produced breakthroughs such as targeted radiotherapy, computer-assisted surgery and robotics and neurosurgical navigation. These products are now sold by companies such as Varian or Medtronic, proving that European technology continues to be state of the art. The medtech sector is increasingly seen by venture capital as an opportunity. This should benefit many start-up companies in Rhône-Alpes and Western Switzerland

Entrée libre et inscription on-line obligatoire
en cliquant sur [je m'inscris]

(Pas encore de compte ? Par ici, c'est gratuit!)

HORAIRE ET LIEU

Wednesday, January 23rd, 2008
15h30 Accueil
16h00 First
18h00 Networking Cocktail

Ramada Park Hotel
Avenue Louis-Casaï 75-77
1216 Cointrin-Genève

The hotel is located near the Geneva's International Airport, the Geneva-Cointrin.
By bus take the line number 10 direction "Aéroport", stop : "Jonc", right in front of the hotel.
CFF railway station, the exhibition centre Geneva Palexpo and the city center.
Car parking available.
Location map

FORWARD

Cet événement est gratuit et ouvert à tous. N'hésitez pas à partager cette invitation.
Au plaisir de vous retrouver mercredi 23 janvier @ Ramada Park Hotel, Genève
Avec nos meilleures salutations

((( Geneviève Morand , Rezonance